Can Fite (Israel) Valuation Overview

CANF -- Israel Stock  

ILS 234.30  1.30  0.56%

Can Fite BioPharma prevailing Real Value cannot be determined due to lack of data. The current price of Can Fite BioPharma is S234.3. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Macroaxis approximates value of Can Fite BioPharma from analyzing the firm fundamentals such as Shares Outstanding of 39.96M, Return On Equity of (73.21)% and Operating Margin of (499.29)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
Horizon     30 Days    Login   to change
Can Fite BioPharma Ltd is rated fourth in price to earning category among related companies. It is number one stock in beta category among related companies .

Current Market Valuation

Can Fite BioPharma Valuation Boundaries

Not valued
October 23, 2018
Market Value
Real Value
Target Odds
Can Fite is Unknown risk asset. Calculation of real value of Can Fite BioPharma is based on 1 month time horizon. Increasing Can Fite BioPharma time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.